These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 16550755)

  • 1. Histological analysis on adhesive molecules of renal intravascular large B cell lymphoma treated with CHOP chemotherapy and rituximab.
    Kusaba T; Hatta T; Tanda S; Kameyama H; Tamagaki K; Okigaki M; Inaba T; Shimazaki C; Sasaki S
    Clin Nephrol; 2006 Mar; 65(3):222-6. PubMed ID: 16550755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intra-vascular large B-cell lymphoma revealed by a nephrotic syndrome: a one year remission induced by a high frequency CHOP and rituximab.
    Girard T; Nochy D; Montravers F; Der Sahakian G; Fior R; Galanaud P; Boué F
    Leuk Lymphoma; 2004 Aug; 45(8):1703-5. PubMed ID: 15370230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.
    Coiffier B; Lepage E; Briere J; Herbrecht R; Tilly H; Bouabdallah R; Morel P; Van Den Neste E; Salles G; Gaulard P; Reyes F; Lederlin P; Gisselbrecht C
    N Engl J Med; 2002 Jan; 346(4):235-42. PubMed ID: 11807147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful treatment of diffuse large B-cell lymphoma following Waldenström's macroglobulinemia with CHOP chemotherapy followed by combination therapy of CHOP with rituximab.
    Uchino K; Sameshima H; Miyamoto T; Iino T; Kato K; Henzan H; Aoki K; Nagafuji K; Gondo H; Harada M
    Intern Med; 2004 Feb; 43(2):131-4. PubMed ID: 15005256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravascular large B-Cell lymphoma with bone marrow involvement and superior sagittal sinus thrombosis: report of a case successfully treated with a CHOP/rituximab combination regimen.
    Jardin F; Callonnec F; Contentin N; Picquenot JM; Gueit I; Héron F; Bastard C; Tilly H
    Clin Lymphoma; 2005 Jun; 6(1):46-9. PubMed ID: 15989707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunochemotherapy is the standard of care in elderly patients with diffuse large B-cell lymphoma.
    Coiffier B; Salles G
    Blood; 2004 Sep; 104(5):1584-5; author reply 1585-6. PubMed ID: 15317734
    [No Abstract]   [Full Text] [Related]  

  • 7. Successful treatment of relapse of an intravascular B-cell lymphoma with rituximab-CHOP polychemotherapy.
    Takács I; Eros N; Bene I; Bozsó F; Tordai L; Károlyi Z; Radványi G; Matolcsy A
    Ann Hematol; 2004 Sep; 83(9):608-10. PubMed ID: 15205915
    [No Abstract]   [Full Text] [Related]  

  • 8. Glomerular infiltration by intravascular large B-cell lymphoma.
    Tian C; Wang X; Zhang Y
    Br J Haematol; 2016 Sep; 174(6):833. PubMed ID: 27391281
    [No Abstract]   [Full Text] [Related]  

  • 9. Fulminant B hepatitis in a surface antigen and hepatitis B DNA-negative patient with diffuse large B-cell lymphoma after CHOP chemotherapy plus rituximab.
    Yamagata M; Murohisa T; Tsuchida K; Okamoto Y; Tsunoda S; Nakamura M; Kusano K; Majima Y; Kuniyoshi T; Iijima M; Sugaya H; Hiraishi H
    Leuk Lymphoma; 2007 Feb; 48(2):431-3. PubMed ID: 17325912
    [No Abstract]   [Full Text] [Related]  

  • 10. Combined therapy with rituximab plus cyclophosphamide/doxorubicin/vincristine/prednisone (CHOP) for Sjögren's syndrome-associated B-cell aggressive non-Hodgkin's lymphomas.
    Voulgarelis M; Giannouli S; Anagnostou D; Tzioufas AG
    Rheumatology (Oxford); 2004 Aug; 43(8):1050-3. PubMed ID: 15187246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fever and nonspecific pulmonary lesions--a rare differential diagnosis].
    Bollinger CR; Theegarten D; Dührsen U; Metz KA
    Dtsch Med Wochenschr; 2007 Nov; 132(48):2563-6. PubMed ID: 18033651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Febrile cellulitis surrounding a scar revealing a large immunoblastic B-cell lymphoma].
    Charavin-Cocuzza M; Templier I; Simon A; Salameire D; Cuchet E; Reymond JL; Beani JC; Leccia MT
    Ann Dermatol Venereol; 2008 Dec; 135(12):848-51. PubMed ID: 19084696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strikingly high false positivity of surveillance FDG-PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab era.
    Avivi I; Zilberlicht A; Dann EJ; Leiba R; Faibish T; Rowe JM; Bar-Shalom R
    Am J Hematol; 2013 May; 88(5):400-5. PubMed ID: 23423884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A 63-old patient with right-sided hypogastric pain at 6 months after appendectomy].
    Handschin D; Zeller A; Wiesner W; Buess M
    Praxis (Bern 1994); 2004 Jan; 93(1-2):24-6. PubMed ID: 14964041
    [No Abstract]   [Full Text] [Related]  

  • 15. CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group.
    Pfreundschuh M; Trümper L; Osterborg A; Pettengell R; Trneny M; Imrie K; Ma D; Gill D; Walewski J; Zinzani PL; Stahel R; Kvaloy S; Shpilberg O; Jaeger U; Hansen M; Lehtinen T; López-Guillermo A; Corrado C; Scheliga A; Milpied N; Mendila M; Rashford M; Kuhnt E; Loeffler M;
    Lancet Oncol; 2006 May; 7(5):379-91. PubMed ID: 16648042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Primary renal lymphoma].
    Torrecilla García-Ripoll JR; Pascual Samaniego M; Martín Blanco S; Rivera Ferro J; Peral Martínez JI; Fernández del Busto E
    Actas Urol Esp; 2003; 27(7):555-8. PubMed ID: 12938588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of intravascular large B-cell lymphoma diagnosed by bone marrow biopsy and FDG-PET scan.
    Takahashi T; Minato M; Tsukuda H; Yoshimoto M; Tsujisaki M
    Intern Med; 2008; 47(10):975-9. PubMed ID: 18480585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CHOP plus rituximab--balancing facts and opinion.
    Cheson BD
    N Engl J Med; 2002 Jan; 346(4):280-2. PubMed ID: 11807154
    [No Abstract]   [Full Text] [Related]  

  • 19. Rituximab, bevacizumab and CHOP (RA-CHOP) in untreated diffuse large B-cell lymphoma: safety, biomarker and pharmacokinetic analysis.
    Ganjoo KN; An CS; Robertson MJ; Gordon LI; Sen JA; Weisenbach J; Li S; Weller EA; Orazi A; Horning SJ
    Leuk Lymphoma; 2006 Jun; 47(6):998-1005. PubMed ID: 16840188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Higher fungal infection rate in elderly patients (more than 80 years old) suffering from diffuse large B cell lymphoma and treated with rituximab plus CHOP.
    Lin PC; Hsiao LT; Poh SB; Wang WS; Yen CC; Chao TC; Liu JH; Chiou TJ; Chen PM
    Ann Hematol; 2007 Feb; 86(2):95-100. PubMed ID: 17031689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.